David G. Kalergis
2019
In 2019, David G. Kalergis earned a total compensation of $475.7K as Chief Executive Officer at Diffusion Pharmaceuticals, a 19% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $50,000 |
|---|---|
| Salary | $410,000 |
| Other | $15,717 |
| Total | $475,717 |
Kalergis received $410K in salary, accounting for 86% of the total pay in 2019.
Kalergis also received $50K in non-equity incentive plan and $15.7K in other compensation.
Rankings
In 2019, David G. Kalergis' compensation ranked 11,895th out of 13,971 executives tracked by ExecPay. In other words, Kalergis earned more than 14.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,895 out of 13,971 | 15th |
Division Manufacturing | 4,815 out of 5,695 | 16th |
Major group Chemicals And Allied Products | 1,900 out of 2,194 | 13th |
Industry group Drugs | 1,637 out of 1,880 | 13th |
Industry Pharmaceutical Preparations | 1,216 out of 1,392 | 13th |
Source: SEC filing on April 29, 2020.
Kalergis' colleagues
We found two more compensation records of executives who worked with David G. Kalergis at Diffusion Pharmaceuticals in 2019.